Tax Exemptions for Non-Profits Making Affordable Drugs and Medical Devices
This law establishes a new tax-exempt status for organizations dedicated to manufacturing and distributing essential drugs and medical devices at affordable prices. The goal is to address shortages and high costs, potentially lowering healthcare expenses for patients and public programs like Medicare. These organizations must also agree to prioritize supplying the national strategic stockpile during emergencies.
Key points
New tax exemptions are created for non-profit entities focused on producing and distributing affordable drugs and medical devices.
The focus is on products that are currently in shortage, excessively expensive, or address unmet public health needs, aiming to reduce patient costs.
Organizations receiving this status must grant the government priority access to at least 25% of their stock for the national strategic stockpile in case of identified need.
Strict rules are implemented to prevent commercial, for-profit pharmaceutical companies from controlling these new tax-exempt organizations.
Status:
Introduced
Civic Will
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens
(explained here).
Start recording it now.